Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Kura Oncology (NQ: KURA ) 19.97 -0.11 (-0.55%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 21, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 377,452 Open 20.11 Bid (Size) 19.00 (1) Ask (Size) 20.20 (1) Prev. Close 20.08 Today's Range 19.74 - 20.50 52wk Range 7.410 - 24.17 Shares Outstanding 68,438,576 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News KURA Stock Earnings: Kura Oncology Beats EPS for Q2 2024 August 08, 2024 KURA stock results show that Kura Oncology beat analyst estimates for earnings per share the second quarter of 2024. Via InvestorPlace 7 ‘Death Cross’ Stocks That Could Be Contrarian Buys July 17, 2024 Although death cross stocks sound incredibly ominous, they could be the ideal time to consider a contrarian position. Via InvestorPlace Performance YTD +30.01% +30.01% 1 Month -3.76% -3.76% 3 Month -9.68% -9.68% 6 Month -1.53% -1.53% 1 Year +82.88% +82.88% More News Read More Acute Myeloid Leukemia is on the Rise as Biotechs Race to Develop Groundbreaking Therapies June 17, 2024 Via FinancialNewsMedia 2 Incredible Growth Stocks to Buy Hand Over Fist May 08, 2024 Via The Motley Fool Kura Oncology Inc. (NASDAQ: KURA) is a Stock Spotlight on 3/6 March 06, 2024 Via Investor Brand Network Kura Oncology: Q4 Earnings Insights February 27, 2024 Via Benzinga Acute Myeloid Leukemia is on the Rise as Biotechs Race to Develop Groundbreaking Therapies June 17, 2024 From FN Media Group LLC Via GlobeNewswire KURA Stock Earnings: Kura Oncology Misses EPS for Q1 2024 May 02, 2024 Via InvestorPlace Earnings Scheduled For February 27, 2024 February 27, 2024 Via Benzinga Earnings Outlook For Kura Oncology February 26, 2024 Via Benzinga Kura Oncology Inc. (NASDAQ: KURA) Near the Top of Equities by Percentage Gain on 1/24 January 24, 2024 Via Investor Brand Network MAIA Biotechnology: Undervalued With Eye-Popping Cancer Data And Partnership Potential February 22, 2024 Via Talk Markets Kura Makes Good On Its $150 Million Infusion And Shoots Up Another 15% January 30, 2024 Via Investor's Business Daily Why UPS Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session January 30, 2024 Via Benzinga Why Cancer-Drug Developer Kura Oncology Stock Is Up January 30, 2024 Via Benzinga General Motors Posts Upbeat Earnings, Joins Corning, HCA Healthcare And Other Big Stocks Moving Higher On Tuesday January 30, 2024 Via Benzinga Topics Stocks Exposures US Equities Dow Edges Lower; US Composite PMI Rises In January January 24, 2024 Via Benzinga Topics Stocks Exposures US Equities Why BlackBerry Shares Are Trading Lower By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session January 24, 2024 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session January 24, 2024 Via Benzinga Why Is Cancer Focused Kura Oncology Stock Is Trading Higher Today? January 24, 2024 Via Benzinga Textron Posts Upbeat Earnings, Joins ASML, Progressive And Other Big Stocks Moving Higher On Wednesday January 24, 2024 Via Benzinga Topics Stocks Exposures US Equities Kura Oncology Rockets 39% Before Unveiling Cancer Drug Test Results — Here's Why January 24, 2024 Via Investor's Business Daily 12 Health Care Stocks Moving In Wednesday's Pre-Market Session January 24, 2024 Via Benzinga Clinical Advancements In Kura Oncology's Lead Program Ziftomenib Hint at Upsurge in Success Likelihood: Analyst December 22, 2023 Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session November 27, 2023 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
